188Re-NM-02
/ NanoMab
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 09, 2024
HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody
(clinicaltrials.gov)
- P1 | N=43 | Completed | Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Recruiting ➔ Completed
Trial completion • Breast Cancer • HER2 Breast Cancer • Oncology • Solid Tumor • HER-2
1 to 1
Of
1
Go to page
1